Cytomegalovirus infection and disease after liver transplantation
Digestive Diseases and Sciences1992Vol. 37(5), pp. 673–688
Citations Over TimeTop 10% of 1992 papers
Robert J. Stratta, Mark S. Shaeffer, Rodney S. Markin, Robert Wood, Alan N. Langnas, Elizabeth Reed, Jeremiah P. Donovan, Gail L. Woods, Kathleen A. Bradshaw, T Pillen, Byers W. Shaw
Related Papers
- → Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients(2007)423 cited
- → Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients(2006)65 cited
- → Use of High-Dose Ganciclovir for the Treatment of Cytomegalovirus Replication in Solid Organ Transplant Patients With Ganciclovir Resistance-Inducing Mutations(2013)54 cited
- → Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised host(2004)7 cited
- [Valganciclovir. Oral treatment of Cytomegalovirus infections].(2004)